« Return to News | Awards & Advancement

Duke University and the Wallace H. Coulter Foundation create $20 million endowment

Thursday, April 21, 2011 12:41 PM

Duke University and the Wallace H. Coulter Foundation have created a $20 million endowment to foster a research collaboration between bioengineers and clinicians with the goal of developing new technologies to improve patient care.

Ten million dollars from the Coulter Foundation will fund the partnership along with additional investments from Duke and the Fitzpatrick Foundation, bringing the total to $20 million.

Elias Caro, vice president of technology development at the foundation, said, "As a member of the Coulter program, Duke adopted the Coulter Process, an industry-like development process, that includes a thorough commercialization analysis which assesses intellectual property, FDA requirements, reimbursement, critical milestones and clinical adoption. This attracted follow-on funding from venture capital and biomedical companies."  

In 2005, the Coulter Foundation picked Duke to move university biomedical engineering projects into commercial products and clinical practices.  Since then, 19 Duke projects have been funded.  Projects surround clinical research areas such as detecting prostate cancer and esophageal pre-cancerous lesions, treating hemophilia and controlling urinary function for paraplegics.

Three startup companies, many licensing agreements, more than $35 million in venture capital and investments, and another $47 million in federal, state or foundation grants have resulted from this partnership. This new endowment will allow for the continued support of promising projects at Duke, said biomedical engineering department chair George Truskey.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.